iShares Genomics Immunology and Healthcare ETFIDNA
IDNA
0
Funds holding %
of 6,810 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
6.08% less ownership
Funds ownership: 35.56% [Q2] → 29.48% (-6.08%) [Q3]
14% less capital invested
Capital invested by funds: $48.1M [Q2] → $41.3M (-$6.76M) [Q3]
16% less funds holding
Funds holding: 61 [Q2] → 51 (-10) [Q3]
55% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 11
62% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 21
Research analyst outlook
We haven’t received any recent analyst ratings for IDNA.
Financial journalist opinion
Positive
ETF Trends
1 month ago
Disruptive Theme of the Week – Breakthroughs in Medicine
Medical breakthroughs are occurring constantly, but they often get lost in the news headlines unless they directly impact our lives. I wanted to take a moment to highlight a few recent medical breakthroughs and developments and explore a few ways to get actionable exposure to them with ETFs.
Positive
Seeking Alpha
10 months ago
IDNA: Healthcare Dashboard For February
This article provides a monthly dashboard with aggregate industry metrics in the healthcare sector. Fast facts on IDNA, a thematic and volatile biotech ETF. We conclude with 10 healthcare stocks cheaper than their peers in February.
Positive
ETF Trends
1 year ago
Disruptive Tech Theme of the Week: 7 Disruptive Themes for 2024
To use a holiday analogy, I have been checking lists and checking them twice to figure out which of next year's top disruptive investment themes are likely to be nice.
Neutral
ETF Trends
1 year ago
VettaFi Voices On: Accessing Disruptive Innovation
Good Morning, VettaFi Voices! Disruptive innovation is a popular topic, and it encompasses everything from bitcoin and cryptocurrency to electric vehicles to artificial intelligence.
Charts implemented using Lightweight Charts™